ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 852 filers reported holding ISHARES TR in Q2 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $147,013,000 | -10.9% | 1,202,157 | -7.5% | 0.04% | -7.0% |
| Q2 2023 | $164,913,000 | -30.0% | 1,298,932 | -28.7% | 0.04% | -35.8% |
| Q1 2023 | $235,441,000 | -2.0% | 1,822,862 | -0.4% | 0.07% | -2.9% |
| Q4 2022 | $240,303,000 | +20.4% | 1,830,315 | +7.3% | 0.07% | +9.5% |
| Q3 2022 | $199,568,000 | -0.2% | 1,706,281 | +0.4% | 0.06% | +6.8% |
| Q2 2022 | $199,883,000 | +20.1% | 1,699,268 | +33.0% | 0.06% | +40.5% |
| Q1 2022 | $166,477,000 | -18.6% | 1,277,636 | -4.7% | 0.04% | -10.6% |
| Q4 2021 | $204,549,000 | -4.8% | 1,340,255 | +0.9% | 0.05% | -17.5% |
| Q3 2021 | $214,809,000 | +26.8% | 1,328,604 | +28.3% | 0.06% | +26.7% |
| Q2 2021 | $169,414,000 | -6.3% | 1,035,225 | -13.8% | 0.04% | -13.5% |
| Q1 2021 | $180,833,000 | -6.5% | 1,201,061 | -5.9% | 0.05% | -7.1% |
| Q4 2020 | $193,386,000 | +23.0% | 1,276,565 | +9.9% | 0.06% | 0.0% |
| Q3 2020 | $157,245,000 | -7.1% | 1,161,245 | -6.3% | 0.06% | -16.4% |
| Q2 2020 | $169,328,000 | +155.5% | 1,238,768 | +101.4% | 0.07% | +109.4% |
| Q1 2020 | $66,283,000 | -24.7% | 615,208 | -15.8% | 0.03% | +3.2% |
| Q4 2019 | $88,078,000 | +11.4% | 730,874 | -8.0% | 0.03% | 0.0% |
| Q3 2019 | $79,075,000 | -14.5% | 794,719 | -6.3% | 0.03% | -16.2% |
| Q2 2019 | $92,522,000 | -7.6% | 848,059 | -5.3% | 0.04% | -14.0% |
| Q1 2019 | $100,155,000 | +34.7% | 895,856 | +16.2% | 0.04% | +19.4% |
| Q4 2018 | $74,338,000 | -21.0% | 770,904 | -0.1% | 0.04% | -7.7% |
| Q3 2018 | $94,100,000 | +5.7% | 771,677 | -4.8% | 0.04% | -2.5% |
| Q2 2018 | $89,052,000 | -7.1% | 810,894 | -9.7% | 0.04% | -7.0% |
| Q1 2018 | $95,902,000 | -11.2% | 898,480 | -11.1% | 0.04% | -8.5% |
| Q4 2017 | $107,937,000 | -25.3% | 1,010,933 | +133.5% | 0.05% | -32.9% |
| Q3 2017 | $144,447,000 | +9.3% | 433,011 | +1.6% | 0.07% | +1.4% |
| Q2 2017 | $132,199,000 | -5.7% | 426,336 | -10.8% | 0.07% | -9.2% |
| Q1 2017 | $140,125,000 | +47.8% | 477,799 | +33.8% | 0.08% | +46.2% |
| Q4 2016 | $94,780,000 | +42.2% | 357,143 | +55.1% | 0.05% | +36.8% |
| Q3 2016 | $66,641,000 | -65.3% | 230,223 | -69.2% | 0.04% | -67.0% |
| Q2 2016 | $192,211,000 | +259.5% | 746,918 | +264.3% | 0.12% | +248.5% |
| Q1 2016 | $53,468,000 | -29.9% | 205,010 | -9.0% | 0.03% | -34.0% |
| Q4 2015 | $76,237,000 | +14.2% | 225,327 | +2.4% | 0.05% | 0.0% |
| Q3 2015 | $66,744,000 | -18.7% | 220,044 | -1.1% | 0.05% | -12.3% |
| Q2 2015 | $82,104,000 | +51.9% | 222,521 | +41.4% | 0.06% | +50.0% |
| Q1 2015 | $54,045,000 | +19.7% | 157,369 | +5.7% | 0.04% | +31.0% |
| Q4 2014 | $45,152,000 | +6.5% | 148,848 | -4.0% | 0.03% | 0.0% |
| Q3 2014 | $42,415,000 | +44.6% | 155,007 | +35.8% | 0.03% | +45.0% |
| Q2 2014 | $29,337,000 | +7.1% | 114,139 | -1.5% | 0.02% | 0.0% |
| Q1 2014 | $27,384,000 | -0.6% | 115,835 | -4.5% | 0.02% | 0.0% |
| Q4 2013 | $27,538,000 | +75.5% | 121,286 | +62.0% | 0.02% | +66.7% |
| Q3 2013 | $15,689,000 | +11.5% | 74,853 | -7.5% | 0.01% | 0.0% |
| Q2 2013 | $14,070,000 | – | 80,913 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Elliott Investment Management L.P. | 4,617,600 | $564,686,304 | 4.37% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 57,250 | $7,001,103 | 4.35% |
| DAFNA Capital Management LLC | 102,500 | $12,534,725 | 3.90% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,306,775 | 3.58% |
| Rye Brook Capital LLC | 40,900 | $5,002 | 3.56% |
| Bronte Capital Management Pty Ltd. | 283,229 | $34,636,074 | 3.49% |
| FWL INVESTMENT MANAGEMENT, LLC | 39,504 | $4,830,944 | 3.24% |
| Alpha Family Trust | 34,568 | $4,227,321 | 3.22% |
| HARBOUR INVESTMENT MANAGEMENT LLC | 40,720 | $4,985,830 | 2.85% |
| CUMBERLAND ADVISORS INC | 51,490 | $6,296,712 | 2.79% |